Related Experiment Video
Updated: Jul 11, 2026
Visualizing the Early Stages of Phagocytosis
Published on: February 3, 2017
Mitoxyperilysis: fasting-induced cell death in immunometabolism and disease
Radhwan Al-Zidan1, Manjul Gautam1, Si Ming Man1
1Division of Immunology and Infectious Diseases, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
Abstract:
Recent work by Wang and colleagues reveals a unique mode of cell death called mitoxyperilysis, driven by mitochondrial proximity-dependent rupture of the plasma cell membrane. This lytic cell death is triggered by immune agonists combined with fasting or nutrient starvation, offering therapeutic implications in sepsis and cancer.
Insights
Scientists discovered mitoxyperilysis, a novel cell death process. It involves mitochondrial rupture of the cell membrane, triggered by immune signals and nutrient deprivation, with potential uses in sepsis and cancer treatment.
Area of Science:
- Cellular Biology
- Immunology
- Pathophysiology
Background:
- Cell death pathways are crucial in disease and therapy.
- Mitochondrial function is central to cellular homeostasis and death.
- Immune agonists and metabolic states influence cell fate.
Purpose of the Study:
- To elucidate a novel cell death mechanism.
- To investigate the role of mitochondrial proximity in cell lysis.
- To explore the therapeutic potential of this cell death mode.
Main Methods:
- Induction of cell death using immune agonists and nutrient starvation.
- Microscopy to observe mitochondrial-plasma membrane interactions.
- Analysis of cell membrane integrity and cell death markers.
Main Results:
- A unique lytic cell death, termed mitoxyperilysis, was identified.
- Cell death is dependent on the proximity of mitochondria to the plasma membrane.
- Immune agonists combined with fasting/starvation trigger this process.
Conclusions:
- Mitoxyperilysis represents a novel, mitochondria-driven cell death pathway.
- This mechanism offers new therapeutic avenues for sepsis and cancer.
- Targeting mitoxyperilysis could provide novel treatment strategies.
More Related Videos
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
05:59Author Spotlight: Oxygen-Independent Assays to Measure Mitochondrial Function in Mammals
Published on: May 19, 2023
